"The R & D budget of just one American company can be many times that of the whole of Taiwan's biotech industry. If Taiwan wants to leverage its abilities, we have to find our own ways forward," says Biowell's chairman, Sheu Jun-jei.
「美國一家公司的研發經費是台灣所有公司加起來的好幾倍，台灣若想以小搏大，一定要想出自己的路，」博微生技公司董事長許俊傑說。